Berlin: Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion (Dh7.6 billion) on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year. Net profit during the final quarter of last year rose 72 per cent from the $1.21 billion net profit posted in the final three months of 2011, when the Basel-based company took a hit from ending its clinical study into wider uses of the hypertension drug Tekturna. Chief Executive Joseph Jimenez said Novartis has a strong range of new products coming out of its research and development pipeline — including a new infant vaccine for meningitis — and predicted net sales to grow after 2013.
Business | Retail
Novartis fourth quarter net profit rebounds to $2.08b
Swiss drug maker’s net profit during the final quarter of last year rose 72%
- AP
- Published: 15:28 January 23, 2013
More from Retail
More from Business
Business Editor's choice
-
Sprint deal puts US in China cyber attack danger
US senator against Japanese company SoftBank Corp’s plan to buy 70 per cent of Sprint Nextel
-
Procter & Gamble brings back Lafley as CEO
Lafley who left in 2009, is returning to the company’s helm
-
IMF chief avoids charges in French scandal
Lagarde was questioned for a total of 24 hours